How did human immunodeficiency virus (HIV) evolve, when was it first identified, and what research has been conducted on its origin?

HIV Evolution, Identification, and Origin Research

HIV evolved from simian immunodeficiency viruses (SIVs) through multiple cross-species transmissions from African primates to humans in the early 20th century, with HIV-1 first identified in archived samples from 1959 and the AIDS pandemic recognized in the early 1980s.

Evolutionary Origins

HIV comprises two distinct types that arose independently from different primate sources:

HIV-1 Origins

• HIV-1 emerged from SIVcpz (simian immunodeficiency virus infecting chimpanzees, Pan troglodytes) in Central Africa, specifically southeastern Cameroon 1
• The virus likely crossed into humans between the 1920s and 1940s, with molecular clock analyses placing the last common ancestor of HIV-1 Group M (the pandemic strain) prior to 1940 2
• The oldest confirmed HIV-1 infection comes from a 1959 plasma sample from the Democratic Republic of Congo (then Zaire), with viral sequences placing it near the ancestral node of subtypes B and D 3
• Phylogenetic evidence suggests all major-group HIV-1 viruses evolved from a single introduction into the African population not long before 1959 3

HIV-2 Origins

• HIV-2 originated from SIVsmm (simian immunodeficiency virus from sooty mangabeys, Cercocebus atys) in West Africa 2, 1
• This represents a separate cross-species transmission event from HIV-1
• HIV-2 remains predominantly endemic in West Africa, particularly former Portuguese colonies 4

Timeline of Identification

Initial Recognition

• AIDS was first recognized as a distinct syndrome in 1981 in the United States, though the causative virus had been circulating for decades
• The virus disseminated through colonial trade networks from Central Africa, reaching the Caribbean by the 1960s before establishing endemic transmission in North America and Europe 5

Diagnostic Development

• HIV-1 antibody tests were rapidly developed in 1985 following identification of the virus 4
• HIV-2 was discovered in 1986 and found to be relatively common in parts of West Africa 4
• The FDA licensed the first HIV-2 antibody test (Genetic Systems HIV-2 EIA) on April 25,1990 4
• Combination HIV-1/HIV-2 screening tests were licensed in 1991-1992, with mandatory blood screening for HIV-2 beginning June 1,1992 4

Genetic Diversity and Evolution

HIV exhibits extraordinary genetic heterogeneity driven by:

Mutation Mechanisms

• High mutation rate of ~10⁻⁵ mutations per base per replication cycle 5
• Rapid replication with generation time of 2.5 days, producing up to 5,000 viral particles per infected cell 6
• Frequent recombination events creating circulating recombinant forms (CRFs) 5

Viral Classification

HIV-1 is categorized into:

• Groups: M (major, >95% of infections), O (outlier), N (non-M/non-O), and P 7, 5
• Subtypes within Group M: A through L, with distinct geographic distributions 5
  • Subtype C predominates in sub-Saharan Africa and Asia
  • Subtype B dominates in Western Europe and North America
  • Each subtype exhibits differential biological properties, transmission efficiencies, and drug resistance profiles

Research on Origins

Key Evidence Sources

Phylogenetic analyses have been fundamental, using:

• Archived clinical samples from the 1950s-1970s 3, 8
• Comparison with SIV sequences from multiple African primate species 2, 1
• Molecular clock modeling to estimate timing of cross-species transmission 8, 2

Geographic correlation studies demonstrate:

• The only viruses closely related to HIV-1 come from chimpanzees in western equatorial Africa 2
• This region coincides with the apparent hearth of the HIV-1 pandemic
• HIV-2's closest relatives are found exclusively in sooty mangabeys from West Africa, matching HIV-2's endemic region 2

Host Adaptation Research

Host restriction factors have shaped viral emergence by:

• Imposing adaptive hurdles to cross-species transmission 1
• Requiring genetic changes for successful secondary spread in humans
• Evidence suggests AIDS likely afflicted chimpanzees long before human emergence 1

Clinical Implications

The extensive genetic diversity significantly impacts:

• Diagnostic accuracy: Different subtypes may show variable detection by certain antibody tests 7
• Antiretroviral therapy efficacy: Subtypes exhibit differential drug resistance profiles 5
• Vaccine development: Cross-subtype protection remains challenging, though broadly neutralizing antibodies show promise 5

For clinical practice: HIV-2 testing should be considered for persons with epidemiologic risk factors including birth in, travel to, receipt of blood products from, or sexual partners from West Africa 7, 4. The prevalence of HIV-2 in the United States remains extremely low, with only 32 cases reported through 1992, predominantly in West African immigrants 4.